gallic acid has been researched along with 2019 Novel Coronavirus Disease in 9 studies
gallate : A trihydroxybenzoate that is the conjugate base of gallic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gallic acid is a phytophenol and shows high binding affinity toward the ACE-2 receptors, which may be helpful for better outcomes in the treatment of COVID-19 pathogenesis." | 3.01 | Therapeutic Role of Phytophenol Gallic Acid for the Cure of COVID-19 Pathogenesis. ( Baraskar, K; Shrivastava, R; Shrivastava, VK; Thakur, P, 2023) |
| "Since the start of the outbreak of coronavirus disease 2019 in Wuhan, China, there have been more than 150 million confirmed cases of the disease reported to the World Health Organization." | 1.62 | GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2. ( Chang, GH; Cheng, YC; Hsu, CM; Lin, YS; Liu, HT; Shen, RC; Shu, LH; Tsai, MS; Wu, CY; Wu, YH; Yang, YH; Yeh, RA, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 9 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banerjee, A | 2 |
| Kanwar, M | 1 |
| Maiti, S | 2 |
| Chelleng, N | 1 |
| Puzari, M | 1 |
| Chetia, P | 1 |
| Tamuly, C | 1 |
| Baraskar, K | 1 |
| Thakur, P | 1 |
| Shrivastava, R | 1 |
| Shrivastava, VK | 1 |
| Sun, J | 1 |
| Liu, Y | 1 |
| Chen, C | 1 |
| Quarm, AK | 1 |
| Xi, S | 1 |
| Sun, T | 1 |
| Zhang, D | 1 |
| Qian, J | 1 |
| Ding, H | 1 |
| Gao, J | 1 |
| Cerqueira, MA | 1 |
| Leite, ACCO | 1 |
| Tomás, AL | 1 |
| Reichel, A | 1 |
| Silva, PM | 1 |
| Santos, NC | 1 |
| Michelin, M | 1 |
| Fuciños, P | 1 |
| Pastrana, LM | 1 |
| Zhang, YN | 1 |
| Zhu, GH | 1 |
| Liu, W | 1 |
| Chen, XX | 1 |
| Xie, YY | 1 |
| Xu, JR | 1 |
| Jiang, MF | 1 |
| Zhuang, XY | 1 |
| Zhang, WD | 1 |
| Chen, HZ | 1 |
| Ge, GB | 1 |
| Ohgitani, E | 1 |
| Shin-Ya, M | 1 |
| Ichitani, M | 1 |
| Kobayashi, M | 1 |
| Takihara, T | 1 |
| Kawamoto, M | 1 |
| Kinugasa, H | 1 |
| Mazda, O | 1 |
| Tsai, MS | 1 |
| Yang, YH | 1 |
| Lin, YS | 1 |
| Chang, GH | 1 |
| Hsu, CM | 1 |
| Yeh, RA | 1 |
| Shu, LH | 1 |
| Cheng, YC | 1 |
| Liu, HT | 1 |
| Wu, YH | 2 |
| Shen, RC | 1 |
| Wu, CY | 1 |
1 review available for gallic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Therapeutic Role of Phytophenol Gallic Acid for the Cure of COVID-19 Pathogenesis.
Topics: COVID-19; Gallic Acid; Humans; Mutation; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2023 |
8 other studies available for gallic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Theaflavin-3'-O-gallate a Black-tea Constituent Blocked SARS CoV-2 RNA dependant RNA Polymerase Active-site with Better Docking Results than Remdesivir.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Biflavonoids; Catalytic Domain; Catechin; Corona | 2021 |
Phenolic compounds of
Topics: Chlorogenic Acid; COVID-19; Gallic Acid; Helicobacter pylori; Molecular Docking Simulation; Phenols; | 2023 |
Cyclophilin D-mediated angiotensin II-induced NADPH oxidase 4 activation in endothelial mitochondrial dysfunction that can be rescued by gallic acid.
Topics: Angiotensin II; COVID-19; Gallic Acid; Human Umbilical Vein Endothelial Cells; Humans; Mitochondria; | 2023 |
Edible alginate-based films with anti-SARS-CoV-2 activity.
Topics: Alginates; Antioxidants; Antiviral Agents; COVID-19; Edible Films; Food Packaging; Gallic Acid; Huma | 2023 |
Discovery of the covalent SARS-CoV-2 M
Topics: Antiviral Agents; COVID-19; Gallic Acid; High-Throughput Screening Assays; Humans; Molecular Docking | 2023 |
Epigallocatechin gallate and theaflavin gallate interaction in SARS-CoV-2 spike-protein central channel with reference to the hydroxychloroquine interaction: Bioinformatics and molecular docking study.
Topics: Angiotensin-Converting Enzyme 2; Biflavonoids; Binding Sites; Catechin; Computational Biology; COVID | 2021 |
Significant Inactivation of SARS-CoV-2 In Vitro by a Green Tea Catechin, a Catechin-Derivative, and Black Tea Galloylated Theaflavins.
Topics: Angiotensin-Converting Enzyme 2; Animals; Antiviral Agents; Biflavonoids; Catechin; Cell Survival; C | 2021 |
GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2.
Topics: Angiotensin-Converting Enzyme 2; Antibodies, Neutralizing; Antioxidants; Antiviral Agents; Biflavono | 2021 |